GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a major focus in medical studies, largely due to its remarkable impact on managing ailments such as adult-onset diabetes and excess body fat. Ongoing research have demonstrated that more than glucose management, GLP-1 drugs offer potential for cardiovascular well-bein